Updates are available Correction dated 2020-12-04
Click to view Correction: https://doi.org/10.1038/s41416-020-01193-w
-
Authors
Turan, Tolga
Kongpachith, Sarah
Halliwill, Kyle
Roelands, Jessica http://orcid.org/0000-0003-3631-2041
Hendrickx, Wouter
Marincola, Francesco M.
Hudson, Thomas J.
Jacob, Howard J.
Bedognetti, Davide
Samayoa, Josue
Ceccarelli, Michele
-
Funding
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (IG2018-21846)
- License Information
-
More Information
Article History
Received: 18 March 2020
Revised: 26 September 2020
Accepted: 15 October 2020
First Online: 5 November 2020
Change Date: 10 February 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41416-020-01193-w
Ethics approval and consent to participate
: All data were from other publications. The ethical approvals obtained for each data set are listed in the original publications.
: Not applicable.
: Raw and source data availability: all raw data used in the study (weblinks, references, cohort sizes and other meta-data attributes) are listed in Table InternalRef removed.
: The source code and installation instructions for MIRACLE R package can be found publicly at GitHub (ExternalRef removed). MIRACLE score can be calculated for a normalised RNAseq or Microarray gene expression matrix allowing the use of various platform identifiers including Ensembl Gene Ids (preferred), U133p2 and U133A from Affymetrix, IlluminaHTv3 and IlluminaHTv4 from Illumina and other expression data sets with features mapped to Entrez IDs or Hugo Gene Symbols. A shinyapp is also available at the following address ExternalRef removed, to enable the use of MIRACLE by non-bioinformaticians.
: T.T., S.K., K.H., T.J.H., H.J.J. and J.S. are all employees of AbbVie. F.M.M. was an employee of AbbVie at the time of the study. M.C. was an employee of AbbVie at the time of the study and at present continues to have consulting relation with AbbVie. J.R., W.H. and D.B. have no current or prior affiliation with AbbVie beyond the current study. The design, study conduct and financial support for this research were provided by AbbVie. AbbVie participated in the interpretation of data, review and approval of the publication.
: The research was funded by AbbVie, Inc. The research leading to these results has also received funding from AIRC under IG 2018 - ID. 21846 project—P.I. Ceccarelli Michele and from Italian Ministry of Research Grant PRIN 2017XJ38A4_004.
